Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Prokaryotic membrane coat - like proteins: An update

  • Ferrelli, Leticia
  • Pidre, Matías L.
  • García-Domínguez, Rubén
  • Alberca, Lucas N.
  • Saz-Navarro, María del
  • Santana-Molina, Carlos
  • Devos, Damien P.
Membrane coat proteins are essential players in the eukaryotic endomembrane traffic system. Previous work identified proteins with the membrane-coat architecture in prokaryotes, specifically in the Planctomycetes, Verrucomicrobia and Chlamydiae (PVC) superphylum, bacteria that display the most developed prokaryotic endomembrane system. Hence, the membrane coat-like (MCL) proteins are predicted to play a central role in this system but their actual function is still unknown. In this work we strengthened previous structure predictions for these prokaryotic MCL proteins. We also detected new putative MCL proteins in the Planctomycete Gemmata obscuriglobus. Structural analysis of these revealed the presence of additional domains apart from the β-propeller and α-solenoid combination, characteristic of the membrane-coat architecture. Functions associated with these domains include some related to carbohydrate or membrane/lipid binding. Using homology-based methods, we found MCL proteins in other bacterial phyla, but the most abundant hits are still restricted to Planctomycetes and Verrucomicrobia. Detailed inspection of neighbouring genes of MCL in G. obscuriglobus supports the idea that the function of these proteins is related to membrane manipulation. No significant hits were found in Archaea, including Asgard archaea. More than 10 years after their original detection, PVC bacteria are still uniquely linked to eukaryotes through the structure of the MCL proteins sustaining their endomembrane system., This work was realised under the framework of the MSC program REFRACT MSCA RISE PROJECT 2019 (H2020 EU GA N 823886). This work was also supported by Mineco, SP (Grant No. PID2020-119733GB-I00) and the “Moore-Simons Project on the Origin of the Eukaryotic Cell” (Grant No. 9733/ DOI https://doi.org/10.37807/GBMF9733) to DPD., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

PED in 2024: improving the community deposition of structural ensembles for intrinsically disordered proteins

  • Ghafouri, Hamidreza
  • Lazar, Tamas
  • Del Conte, Alessio
  • Tenorio Ku, Luiggi G.
  • Tompa, Peter
  • Tosatto, Silvio C. E.
  • Monzon, Alexander Miguel
9 pags., 2 figs., The Protein Ensemble Database (PED) (URL: https://proteinensemble.org) is the primary resource for depositing structural ensembles of intrinsically disordered proteins. This updated version of PED reflects advancements in the field, denoting a continual expansion with a total of 461 entries and 538 ensembles, including those generated without explicit experimental data through novel machine learning (ML) techniques. With this significant increment in the number of ensembles, a few yet-unprecedented new entries entered the database, including those also determined or refined by electron paramagnetic resonance or circular dichroism data. In addition, PED was enriched with several new features, including a novel deposition service, improved user interface, new database cross-referencing options and integration with the 3D-Beacons network-all representing efforts to improve the FAIRness of the database. Foreseeably, PED will keep growing in size and expanding with new types of ensembles generated by accurate and fast ML-based generative models and coarse-grained simulations. Therefore, among future efforts, priority will be given to further develop the database to be compatible with ensembles modeled at a coarse-grained level., European Union’s Horizon 2020 research and innovation programme [778247 MSCA-RISE ‘IDPfun’ and 823886 MSCA-RISE ‘REFRACT’]; ML4NGP CA21160 project supported by COST (European Cooperation in Science and Technology) under Horizon Europe; H.G. and M.C.A. are funded by the European Union—NextGenerationEU through ‘Italiadomani—PNRR’ projects ‘National Centre for HPC, Big Data and Quantum Computing’ [codice identificativo MUR CN00000013, C93C22002800006]; ‘National Center for Gene Therapy and Drugs based on RNA Technology’ [codice fiscale 92315700283, codice identificativo CN00000041]; ELIXIR, the research infrastructure for life-science data, and by the European Union—NextGenerationEU through ‘Italiadomani—PNRR project IR000010 ‘ELIXIR × NextGenerationIT:Consolidamento dell’Infrastruttura Italiana per i Dati Omici e la Bioinformatica—ElixirxNextGenIT’ and project ECS00000017 ‘THE—Tuscany Health Ecosystem’. T.L. is holder of a postdoctoral innovation mandate [HBC.2022.0194] by the Flanders Innovation & Entrepreneurship Agency (VLAIO). Funding for open access charge: European Union’s Horizon 2020 research and innovation programme [778247 MSCA-RISE “IDPfun” and 823886 MSCA-RISE “REFRACT”]., Peer reviewed